NUREXONE BIOLOGIC INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.52 CAD | +1.96% |
|
+4.00% | +76.27% |
| 04-25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
| 04-02 | NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on NurExone Biologic Inc.
Price target over the last 5 years
History of analyst recommendation changes
a933ae589ae16f87442a6316cc11d8ab.f8uqc2UXPCSmD5JohY7tTOTaXLgHYDzmKQ8fCa3slVw.Cb77JQIjDnfvafQx8OOHIqqCHtRIMmmuTWpzPeS8_2tMj-UwEUJeSPY8qg~9160ae81fee47e8782f7a0e1392edb79
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3811
USD
Average target price
2.907
USD
Spread / Average Target
+662.72%
High Price Target
2.907
USD
Spread / Highest target
+662.72%
Low Price Target
2.907
USD
Spread / Lowest Target
+662.72%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- NRX Stock
- Consensus NurExone Biologic Inc.
